JENKEM: Currently, the applicable U.S. tariff rate for the company's products has not changedZhitong·Oct 15, 2025 at 03:01 AM688356+0.43%
A-share innovative drug concept stocks fluctuated lower, with InventisBio falling over 10%. Other stocks such as Huahai Pharmaceutical, JENKEM, Lifeon Pharmaceutical, JOINN, Guangsheng Tang, HitGen, and Baillie Gifford also dropped more than 6%Zhitong·Sep 9, 2025 at 01:19 AM688356+0.43%603127+3.72%
JENKEM: Wu Kaiting plans to reduce his holdings by no more than 2%Zhitong·Sep 8, 2025 at 06:19 AM688356+0.43%
Innovative drug concept stocks are repeatedly active, Chimin hits the daily limitZhitong·Sep 3, 2025 at 08:41 PM688356+0.43%688658+2.16%
JENKEM: Actively exploring the optimization of existing R&D processes through AIZhitong·Sep 2, 2025 at 02:36 AM688356+0.43%
JENKEM released its semi-annual performance, with a net profit attributable to the parent company of 22.05 million yuan, a year-on-year decrease of 21.08%Zhitong·Aug 28, 2025 at 06:34 AM688356+0.43%
The A-share chemical pharmaceutical sector continues to rise, with TIBET AIM PHARM hitting the limit up, and TIANYU PHARM, CSBIO, Zhendong Pharmaceutical, Menovo, JENKEM, and GuangShengTang following suitZhitong·Aug 11, 2025 at 12:37 AM688356+0.43%300702-0.15%
The concept of innovative drugs has strengthened again, with Hotgen rising over 10% to reach a new historical highZhitong·Aug 5, 2025 at 08:39 PM002773+0.37%688068+4.55%
The A-share innovative drug concept continues to be strong, with YABAO PHARM.CORP hitting the limit up, and JENKEM, HSGC, YKYY, MEDISAN, HITECK, and others leading in gainsWallstreetcn·Jul 23, 2025 at 08:32 PM600351+0.94%688356+0.43%
JENKEM: The company's production and operation are normal, and there are no significant matters that should be disclosed but have not been disclosedZhitong·Jul 21, 2025 at 05:05 AM688356+0.43%
The concept of innovative drugs has strengthened again, with Staidson BioPharm rising over 15%, reaching a three-year highZhitong·May 28, 2025 at 08:42 PM603707-0.61%688336+3.61%
JENKEM: Application for registration of sodium hyaluronate injection composite solution acceptedZhitong·May 28, 2025 at 03:56 AM688356+0.43%
JENKEM: Subsidiary's new product obtains medical device registration certificateZhitong·Apr 25, 2025 at 03:48 AM688356+0.43%
JENKEM established a life sciences technology company in HainanZhitong·Apr 14, 2025 at 09:17 PM688356+0.43%
CanSinoBIO and JENKEM Strategic Cooperation to Explore New mRNA Vaccine Tumor Immunity SolutionsZhitong·Apr 9, 2025 at 07:21 AM688185+1.43%06185+0.43%
